{"ticker": {"uuid": "6537d3d2-6859-4b40-ae3c-8cb416d81c68", "symbol": "INGN", "name": "Inogen Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Inogen to report Q2 2026 results after market close, host conference call", "summary": "Inogen (NASDAQ: INGN) has scheduled the release of its second-quarter 2026 financial results for August 6, 2026, after the market closes. The company will also host an earnings call on the same day at 2 p.m. PT (5 p.m. ET), with a webcast available through its investor relations ", "url": "https://www.bitget.com/amp/news/detail/12560605510627", "source_name": "Bitget", "published_at": "2026-07-17T02:11:40", "published_display": "17 Jul 2026 02:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen to report second quarter 2026 results on August 6", "summary": "Inogen will release its second quarter 2026 financial results after market close on Thursday, August 6, 2026. The medical technology company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss its performance. Investors can access the live webcast or a replay, w", "url": "https://scanx.trade/stock-market-news/companies/inogen-to-report-second-quarter-2026-results-on-august-6/45757144", "source_name": "scanx.trade", "published_at": "2026-07-16T14:10:47", "published_display": "16 Jul 2026 14:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inogen-report-second-quarter-2026-123000986.html", "source_name": "Business Wire", "published_at": "2026-07-16T12:30:00+00:00", "published_display": "16 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen schedules Aug. 6 call with live webcast and replay", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNLXVJd19LV2tDcV9hcjhIUmZGejd6SHdEeksydUVHYzhvdnExQ0ZKUXI3ZTRheDVjb1VyNGtZR0NPS3RSX0FZVVFjbWV2ZUhpaVRfR1R2czJDNXRvOWh4YzJBWGU0WlJGTGFDVTF6T1NwOTNuckFSLWtoY25jWjJEaTZEN0ZWUjM1WXVmOVk0X3JjS0Y5aHV3d2ZUUE1NcGRjTXJUaWN4d3RRZDNwYjF2QlRhemRnLUVsR2d6VmhR?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-16T12:30:00+00:00", "published_display": "16 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release: Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026", "summary": "Inogen is scheduled to report its second-quarter 2026 financial results on August 6, 2026, after the market closes. The company will also hold a conference call and live webcast to discuss these results on the same day. Investors can access the webcast or dial into the call for p", "url": "https://www.moomoo.com/news/post/73078092/press-release-inogen-to-report-second-quarter-2026-financial-results?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-16T12:11:40", "published_display": "16 Jul 2026 12:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Inogen (INGN) Stifel 2024 Healthcare Conference Summary", "summary": "Inogen (INGN) shared a summary of their Stifel 2024 Healthcare Conference, detailing efforts in leadership and culture transformation under new CEO and CFO focused on growth, profitability, and innovation. The company is rebaselining its DTC business for profitability, scrutinizi", "url": "https://quartr.com/events/inogen-ingn-stifel-2024-healthcare-conference_onIojeOv", "source_name": "Quartr", "published_at": "2026-07-11T08:10:19", "published_display": "11 Jul 2026 08:10", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Inogen Inc For: 9 July By Investing.com", "summary": "This article reports on a Form 4 filing for Inogen Inc (IGN) relating to transactions on July 9, 2026. The brief piece indicates that Inogen Inc. has a stock symbol INGN and includes its current performance at the time of publication. The content primarily serves as a notificatio", "url": "https://ng.investing.com/news/stock-market-news/form-4-inogen-inc-for-9-july-93CH-2593317", "source_name": "Investing.com Nigeria", "published_at": "2026-07-09T14:10:00", "published_display": "09 Jul 2026 14:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen (INGN) EVP, COO Andrew Reding files baseline Form 3 insider report", "summary": "Inogen Inc.'s EVP and COO, Andrew P. Reding, has filed an initial Form 3 with the SEC, establishing his status as an insider with the company. This filing is a baseline report of beneficial ownership and does not indicate any purchases, sales, or other transactions of company sha", "url": "https://www.stocktitan.net/sec-filings/INGN/form-3-inogen-inc-initial-statement-of-beneficial-ownership-8b078c8ffe9c.html", "source_name": "Stock Titan", "published_at": "2026-07-09T13:11:02", "published_display": "09 Jul 2026 13:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen (INGN) EVP, COO awarded 130,000 restricted stock units vesting from 2026", "summary": "Inogen Inc.'s EVP and COO, Andrew P. Reding, has been granted 130,000 restricted stock units (RSUs). These RSUs will begin vesting on September 1, 2026, with one-third vesting after one year and the remaining units vesting in equal annual installments, contingent on his continued", "url": "https://www.stocktitan.net/sec-filings/INGN/form-4-inogen-inc-insider-trading-activity-bc352f9307cd.html", "source_name": "Stock Titan", "published_at": "2026-07-09T13:11:02", "published_display": "09 Jul 2026 13:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc (INGN) executive sells 10,938 shares in planned trade", "summary": "Jennifer M. Yi Boyer, EVP Enterprise Enablement and Chief HR Officer at Inogen Inc (INGN), sold 10,938 shares of company common stock for $6.5959 per share on July 1, 2026. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on February 27, 2026. ", "url": "https://www.stocktitan.net/sec-filings/INGN/form-4-inogen-inc-insider-trading-activity-e7258f38e9d2.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:10:13", "published_display": "06 Jul 2026 20:10", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INGN - Inogen Inc Volatility & Greeks", "summary": "This article provides a detailed overview of Inogen Inc (INGN) financial data, including its stock performance, volatility metrics, and various financial ratios. It covers key figures such as market capitalization, sales, earnings per share, insider and institutional ownership, a", "url": "https://finviz.com/stock?t=INGN&ta=1&p=d&ty=ocv&b=2&r=m3&e=2026-02-20", "source_name": "Finviz", "published_at": "2026-07-03T17:09:19", "published_display": "03 Jul 2026 17:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc (INGN) Slips Slightly Amidst Range-Bound Trading - Price Surge Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQaGlRWElIc3pBUHhZM0VJZm9qd1NGbTZKUC1zLTRsV0dzUGVoX2RMTG5EVm1HbW9oX1N5UHJOcTVuSlRpSjdUMzl2VS1FNlNCT19VRWQ2QUxfM1lpMUNSVkozbFRBeTBMekgzdmk5dDlhd3ExWEtFWHloN2hQQk9nUWNQdl9INDRZNGxkOFVyOTZ6S0lhN0NwSHQ5Ti1Xb2s?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Appoints New Chief Operating Officer for Growth", "summary": "Inogen has appointed Andy Reding as its new Chief Operating Officer, a move aimed at strengthening its leadership and execution capabilities to support diversification, new product launches, and geographic expansion. Reding brings over 30 years of experience in medical technology", "url": "https://www.theglobeandmail.com/investing/markets/stocks/INGN-Q/pressreleases/3106716/inogen-appoints-new-chief-operating-officer-for-growth/", "source_name": "The Globe and Mail", "published_at": "2026-07-03T03:10:14", "published_display": "03 Jul 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Announces the Appointment of Andy Reding as Chief Operating Officer", "summary": "Inogen, Inc. (Nasdaq: INGN) has appointed Andy Reding as its new Chief Operating Officer, a newly created role aimed at strengthening leadership and driving commercial and operational execution. Reding brings over 30 years of medical technology and commercial operations experienc", "url": "https://www.biospace.com/press-releases/inogen-announces-the-appointment-of-andy-reding-as-chief-operating-officer", "source_name": "BioSpace", "published_at": "2026-07-02T04:10:13", "published_display": "02 Jul 2026 04:10", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Appoints Reding to New COO Role", "summary": "Inogen has appointed Jason Reding as its new Chief Operating Officer, a newly created role within the company. Reding brings extensive experience in general management, operations, and supply chain across various industries, including medical devices. This strategic hire is expec", "url": "https://www.moomoo.com/news/post/72351373/inogen-appoints-reding-to-new-coo-role?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-02T03:10:14", "published_display": "02 Jul 2026 03:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Names Chief Operating Officer", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inogen-names-chief-operating-officer-203207435.html", "source_name": "MT Newswires", "published_at": "2026-07-01T20:32:07+00:00", "published_display": "01 Jul 2026 20:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen appoints Andy Reding as chief operating officer", "summary": "Inogen Inc. has appointed Andy Reding as its new Chief Operating Officer, a newly created position aimed at strengthening its leadership structure. Reding brings over 30 years of experience in medical technology and will be responsible for revenue and operational performance, ali", "url": "https://www.investing.com/news/company-news/inogen-appoints-andy-reding-as-chief-operating-officer-93CH-4771445", "source_name": "Investing.com", "published_at": "2026-07-01T21:09:47", "published_display": "01 Jul 2026 21:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc SEC Filing", "summary": "This SEC Form 144 filing indicates a proposed sale of 10,770 shares of Inogen Inc. (INGN) common stock by Jennifer Yi Boyer, dated May 29, 2026, under a 10b5-1 plan. The filing also notes 10,938 Restricted Stock Units acquired on March 1, 2025, with Morgan Stanley Smith Barney LL", "url": "https://www.stocktitan.net/sec-filings/INGN/144-inogen-inc-sec-filing-e85f308712cd.html", "source_name": "Stock Titan", "published_at": "2026-07-01T21:09:47", "published_display": "01 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen (Nasdaq: INGN) adds COO Andy Reding with equity package", "summary": "Inogen (Nasdaq: INGN) has appointed Andy Reding as its new Chief Operating Officer, effective July 6, 2026, a newly created role to drive revenue, operations, and cross-functional execution for new products and geographic expansion. Reding's compensation package includes a $500,0", "url": "https://www.stocktitan.net/sec-filings/INGN/8-k-inogen-inc-reports-material-event-0b294382a61d.html", "source_name": "Stock Titan", "published_at": "2026-07-01T20:09:47", "published_display": "01 Jul 2026 20:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen adds a COO as it pushes new products and global expansion", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNd0V2UEVlSVlBT3dyNFR2aUR5aFZqNHBmWlByQzJCaTQxTURtVlF5Z0hNcnhjZlZNaEctTGRtMy1nVEVQa3pza3IyNXEyVTZraXY5NHZocVYtRjA1cVFhY2JnTHc5SkF5TXVhZEUtV0tueDNxZ1lGenI3RVFpS216QXVXbHVYOGo1R0J6ZFZCeHJrTjROeFhXOVE5RmxGeWx3bGhaMHFlQXBGdUNjRnhCX2ZSTEZtWFB4SkJRMDNB?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] Inogen Inc SEC Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPWVBHQUhQYU9FYlYtOUcxVXhEOTRHWW5zYktKZkNSOGlIY0tmam5HZGVCVUtmVlc3SGlDbXpDNnlfRXlCelhyWEdKY25TdHh5aVZKUHhHWkd2VDFZM2dEdWhZWWxCVkdEdVJYRUZRTF9KM0NLZThQWkVyd2h3NnBFWXAyNTM1N3V6WmVVYmh3bWk?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen, Inc. Financial Disclosures & Filings", "summary": "This page provides a comprehensive list of Inogen, Inc.'s financial disclosures and filings, including earnings reports, annual general meetings, corporate presentations, and investor conference transcripts from 2022 to 2026. These documents offer insights into the company's fina", "url": "https://www.tradingview.com/symbols/LSX-A1XB32/documents/", "source_name": "TradingView", "published_at": "2026-07-01T03:40:59", "published_display": "01 Jul 2026 03:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen, Inc. Actuals & Estimates (NASDAQ:INGN)", "summary": "This article provides an overview of Inogen, Inc.'s (NASDAQ: INGN) financial actuals and estimates, including its current stock price, historical performance, analyst forecasts, and upcoming earnings report. It highlights the company's financial data, such as market capitalizatio", "url": "https://www.tradingview.com/symbols/NASDAQ-INGN/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T05:40:29", "published_display": "27 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen, Inc. Actuals & Estimates (SWB:6IO)", "summary": "This article provides financial actuals and estimates for Inogen, Inc. (SWB:6IO), including income statement, balance sheet, and cash flow data, alongside analyst price targets. It details the company's past earnings and revenue, future earnings report dates, and key financial me", "url": "https://www.tradingview.com/symbols/SWB-6IO/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T01:40:29", "published_display": "27 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Inogen, Inc \u2013 NASDAQ:INGN", "summary": "This article displays the \"Price to sales forward\" metric for Inogen, Inc (NASDAQ: INGN) on the TradingView platform. The content is primarily a representation of financial data for the company, showing a period, value, change, and percentage change without specific figures in th", "url": "https://www.tradingview.com/symbols/NASDAQ-INGN/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T18:40:29", "published_display": "26 Jun 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Inogen, Inc \u2013 NASDAQ:INGN", "summary": "This article provides financial information for Inogen, Inc (NASDAQ: INGN), specifically its enterprise value to revenue forward. It appears to be a stub or an incomplete data entry from a financial platform like TradingView, as it lacks detailed analytical content beyond the sta", "url": "https://www.tradingview.com/symbols/NASDAQ-INGN/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T18:39:30", "published_display": "26 Jun 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision Trading with Inogen Inc (INGN) Risk Zones", "summary": "This article provides a precision trading analysis for Inogen Inc (INGN), detailing neutral readings in shorter horizons and suggesting an easing of a long-term weak bias. It highlights an exceptional 49.5:1 risk-reward setup targeting a 15.8% gain versus 0.3% risk, and outlines ", "url": "https://news.stocktradersdaily.com/news_release/22/Precision_Trading_with_Inogen_Inc_INGN_Risk_Zones_061926123202_1781886722.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-19T12:32:01", "published_display": "19 Jun 2026 12:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc (INGN) Institutional Confidence", "summary": "The article analyzes Inogen Inc's (INGN) institutional confidence score, which is currently 7.00, placing it 79th in its industry. Institutional shareholding rose by 4.39% quarter-over-quarter to 75.89%, with Steven Cohen being the largest shareholder despite a slight decrease in", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ingn/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T08:14:46", "published_display": "18 Jun 2026 08:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc (INGN) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Inogen Inc (INGN), outlining its major shareholders and institutional holdings. It provides a breakdown of shareholder types, including investment advisors, hedge funds, and corporations, and tracks changes in institutional shareh", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ingn/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T09:41:18", "published_display": "17 Jun 2026 09:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc (INGN) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE5xWmlNOE8zUU9BcDFXUlJxNWJQYTFYVGJwS0FrZ0tqQUVldklFLTFQZUtGbWgxY1J2WDhiaWlsT2toRE84VlBTeDBIaUs5X21Zbm1RUU05QzZLVWhOMDFla3dfNmFGMFI5VEJuWUFTTGpKWHA3Z1FHMQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-16T22:51:25+00:00", "published_display": "16 Jun 2026 22:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc (INGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a brief overview of Inogen Inc's (INGN) revenue breakdown by region, indicating that 60.18% of its revenue comes from the U.S. and 39.82% from non-U.S. sources. It also lists various financial reporting periods (FY2025-FY2020) but states that relevant data f", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ingn/revenue", "source_name": "TradingKey", "published_at": "2026-06-16T22:39:52", "published_display": "16 Jun 2026 22:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc (INGN) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of Inogen Inc (INGN), highlighting its current market data and valuation score. The company's valuation score is 8.86, placing it 63rd in the Healthcare Equipment & Supplies industry. Key financial ratios like P/E, P/B, P/S, and P/CF are", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ingn/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-16T20:10:03", "published_display": "16 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc (INGN) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for Inogen Inc (INGN), highlighting its current earnings forecast score, average price target, and analyst ratings. Based on three analysts, the stock has an average target price of $13.00, with a \"Buy\" recommendation. The article also i", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ingn/earnings", "source_name": "TradingKey", "published_at": "2026-06-16T19:41:18", "published_display": "16 Jun 2026 19:41", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc Stock (US45780L1044): Valuation metrics under the microscope", "summary": "This article examines the valuation metrics of Inogen Inc (INGN), a medical technology company specializing in portable oxygen concentrators. Due to recent operating losses, traditional price-earnings ratios are not relevant; instead, investors focus on price-to-sales and enterpr", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/inogen-inc-stock-us45780l1044-valuation-metrics-under-the-microscope/69547852", "source_name": "AD HOC NEWS", "published_at": "2026-06-15T21:09:50", "published_display": "15 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "INGN SEC Filings - Inogen Inc 10-K, 10-Q, 8-K Forms", "summary": "This page on StockTitan provides a comprehensive resource for Inogen Inc. (INGN) SEC filings, including 10-K annual reports, 10-Q quarterly reports, and 8-K material event disclosures. It details Inogen's business in respiratory medical technology and lists recent filings with AI", "url": "https://www.stocktitan.net/sec-filings/INGN/page-5.html", "source_name": "Stock Titan", "published_at": "2026-06-12T18:40:41", "published_display": "12 Jun 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen (INGN) director awarded 28,081 RSUs, boosting share holdings", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOVGVUU0lZdUZLNVk5RWR2NklRakFHUlUwaUpvS0NPbWRib09SUzFvdkU5X0RGQ3ZRZFdzMUEteXNseDdKcUJhRm5uRVBPMS12MFNXS3Y0XzNaME1NRlZIRTNGZ1ZZS21WU1RkNmE1NzRXRVA2T3B0ZFZpUFhvdDE4WWdEaTVvaTE3dDFORlpxUC1BbGprU1NNaFA5TmRaX3Q0UVhlSjd6QQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why You Should Retain Inogen Stock in Your Portfolio for Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQaGV1SXNpOVN2R19UNm5PVkpFVlVyaklQYThQd1dVWFdfYllPWkltdnh6Q1padkZ2S3VSeWlaMTEzeTdUNWM4bHdpRTU2cnYyQ2o3UXBpRFdlaXBHR1RsQ3NIMEtGTGQ3ZjJ2c3dyQ0l0bTE0dU9ycEIxTnJVVVpZMWg2UEx5b1dBd3NaeG5ibFZwOURWcFR1NDMxYnEyVkU?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "How The Inogen (INGN) Story Is Shifting With New Targets And Execution Questions", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOZUIwNkhCNk9RZXczTmhfbjdiNkNUb2Z5LTZjMnFrbWhaV09BU1B5VTV1Z1VrNUJXamNtd2hnWDJiRTc4S0tzUHVTUzQtNEZiZmt2U1NKdUYtU2NZZVJGdnF5ME9xLWNORGpOLTBteE5raGJWTC0tb0FpRXpFaXl1OEttSS1jSG9qV2JHdDUwaWtoNW5kdV9qZXRKb0dVU2dN?oc=5", "source_name": "Market source", "published_at": "2026-05-10T07:00:00+00:00", "published_display": "10 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen (INGN) Reports Strong Q1 Revenue Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNRUxaUjhwbzhOUnNlUDVDTm5GQTdfUHQ0NFl1SUhoQkpELXZtdmp1Q2lyTHhDVUZwS2J0bTlVbUMxek1seVU1TVRpSXBZOUpycms2d2g5eDVlc0hFejFsZTJWbUQxMEpsMWZlUFZoLTlHNEZ6YkhDNGxVVk1IYmx5UG83YS1GTVd2STN3and1TlBvZVdwUW9vUHlEYw?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNTEpTSHZKNE93eE5YNDJDcVJEYXd6M3lLODlPRFpudEhfbG1KMWpLMDRKUDFpdTFVa0QtdzZpekNOdW9fdVRDYnFNMDluQ1FnRXUtOGhhMURadFBHMmJaaHJIWkJ4SEtQdEgwX2pUektqbnNsMGM3UUZQZXdlYTNBdTRodmlKdlhjNDBhVjYxQmlDbWhvblNvdFRpUmI?oc=5", "source_name": "Market source", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/f03564eb-3491-37ce-a5a4-07799bf50b8a/inogen-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-08T04:06:43+00:00", "published_display": "08 May 2026 04:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen (INGN) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/ab29362c-427b-38f6-8db8-d8a6f09fd441/inogen-%28ingn%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-08T00:08:25+00:00", "published_display": "08 May 2026 00:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen (INGN) Reports Q1 Loss, Beats Revenue Estimates", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/inogen-ingn-reports-q1-loss-230522436.html", "source_name": "Zacks", "published_at": "2026-05-07T23:05:22+00:00", "published_display": "07 May 2026 23:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We're Not Very Worried About Inogen's (NASDAQ:INGN) Cash Burn Rate", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPcVN3N012OUhRQUZXTTFIVkI0b1ozUVAzWDNiaG9UZzJQeDdZMm5taEtXV21vZy1SV1JuejJJUFpJcExpZjlBTVluM1pOVmtXbmRnWTFyUmJmWkZSNGVBWWttdzhfMEZqbFRJTnVtUER4WE5kWW9QMlNrdFFFZ2RYQXVYRnRSNmM2Y01ocW5keEFSRHVWR2s1TUNB?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Inogen (INGN) Surges 6.9%: Is This an Indication of Further Gains?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPS0dFNWVfdzhWejY0Vm9lTU9jM2Y5eUJWTDZ2YTlQaGlIMmVqeHk5YVE1MU5zWVE0WUJiOVdRb3REbkVBUnYxMERuOWNOcEFmbXRFM1I5eWlVLVg4Q3phaGJpVFQ1UzcxWmNrVDlwdFdlM1diV3hzaE5MeVdhaUdVZklVamphVDFwaE1LRTV3YnU?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Inogen (NASDAQ:INGN shareholders incur further losses as stock declines 11% this week, taking five-year losses to 86%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why You Should Add Inogen Stock to Your Portfolio Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPX0wzOXJSYzZ1MDhYS2E1UEdvMmlTZ3dENzNJU0V6SlQ2NnlSeC1xQUoyQnoxQzNBSXQ1ZEFrSGJpNHZMSjVHc1ZtUmpwWHZoalhQelQ0Y0pwcnViZC05aUNEUXlla0JmdmxseFJLLVZGc0tfSWd0WE1PZDcyOFpvVUhSOTROZHVKbGkyNlYtSUhFcUQyTmlzbTR6QWhNUmRsaW9WQ2xXSW9EQlRKX3cyaVZhanJRWVk?oc=5", "source_name": "TradingView", "published_at": "2025-07-16T07:00:00+00:00", "published_display": "16 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen launches Voxi 5 stationary oxygen concentrator for long-term care patients", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPZWxsUm9IbUxZRVdMQXk4Qm5HUkZoU2JkTXdwRlBDNDVxR1I5Tk5FTV82b21NbWlrSUZENzZadWNJWjQxeVRvVFhjZ0M2UWFBQkRReGN0eVNGUzk3Rmp3VlNRc0NWSW9HaFNYTF9aM2dmaVpfcDQ5X2FyOVpzSEJOM2Z6eXJLa01wUWUwZGQxRXB4MFJTSzY4NThxZGFrTEptcXhSZG9zT20yUlQ5WUJsZ0xrTW11Tl85Tnc0?oc=5", "source_name": "Medical Economics", "published_at": "2025-06-23T07:00:00+00:00", "published_display": "23 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Yuwell to invest $27m in Inogen to boost oxygen potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPeVpmSjNzdllBSkNoMzhUSm95Vl9sY25rSUZqYkVONEJwMG9qWWFodHBER1E2VFlBaTZuWlFaUFhrV0J4YnVteWo2dDZVQm8ycnU0VHNuZFM1UXM1WF94cEstQVlWZEdNRWxKQTVOdFdnaE1fd0oyV0Z5Rno5UDVMNGlvX1ZzVTMwQ2w5Yk9qcWxtRkZ6LV8wX3hPcTFHU3Iwd2Z6ZWU3cw?oc=5", "source_name": "gasworld", "published_at": "2025-01-28T08:00:00+00:00", "published_display": "28 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Inogen to report Q2 2026 results after market close, host conference call", "summary": "Inogen (NASDAQ: INGN) has scheduled the release of its second-quarter 2026 financial results for August 6, 2026, after the market closes. The company will also host an earnings call on the same day at 2 p.m. PT (5 p.m. ET), with a webcast available through its investor relations ", "url": "https://www.bitget.com/amp/news/detail/12560605510627", "source_name": "Bitget", "published_at": "2026-07-17T02:11:40", "published_display": "17 Jul 2026 02:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen to report second quarter 2026 results on August 6", "summary": "Inogen will release its second quarter 2026 financial results after market close on Thursday, August 6, 2026. The medical technology company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss its performance. Investors can access the live webcast or a replay, w", "url": "https://scanx.trade/stock-market-news/companies/inogen-to-report-second-quarter-2026-results-on-august-6/45757144", "source_name": "scanx.trade", "published_at": "2026-07-16T14:10:47", "published_display": "16 Jul 2026 14:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inogen-report-second-quarter-2026-123000986.html", "source_name": "Business Wire", "published_at": "2026-07-16T12:30:00+00:00", "published_display": "16 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen schedules Aug. 6 call with live webcast and replay", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNLXVJd19LV2tDcV9hcjhIUmZGejd6SHdEeksydUVHYzhvdnExQ0ZKUXI3ZTRheDVjb1VyNGtZR0NPS3RSX0FZVVFjbWV2ZUhpaVRfR1R2czJDNXRvOWh4YzJBWGU0WlJGTGFDVTF6T1NwOTNuckFSLWtoY25jWjJEaTZEN0ZWUjM1WXVmOVk0X3JjS0Y5aHV3d2ZUUE1NcGRjTXJUaWN4d3RRZDNwYjF2QlRhemRnLUVsR2d6VmhR?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-16T12:30:00+00:00", "published_display": "16 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release: Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026", "summary": "Inogen is scheduled to report its second-quarter 2026 financial results on August 6, 2026, after the market closes. The company will also hold a conference call and live webcast to discuss these results on the same day. Investors can access the webcast or dial into the call for p", "url": "https://www.moomoo.com/news/post/73078092/press-release-inogen-to-report-second-quarter-2026-financial-results?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-16T12:11:40", "published_display": "16 Jul 2026 12:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen (INGN) Stifel 2024 Healthcare Conference Summary", "summary": "Inogen (INGN) shared a summary of their Stifel 2024 Healthcare Conference, detailing efforts in leadership and culture transformation under new CEO and CFO focused on growth, profitability, and innovation. The company is rebaselining its DTC business for profitability, scrutinizi", "url": "https://quartr.com/events/inogen-ingn-stifel-2024-healthcare-conference_onIojeOv", "source_name": "Quartr", "published_at": "2026-07-11T08:10:19", "published_display": "11 Jul 2026 08:10", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Inogen Inc For: 9 July By Investing.com", "summary": "This article reports on a Form 4 filing for Inogen Inc (IGN) relating to transactions on July 9, 2026. The brief piece indicates that Inogen Inc. has a stock symbol INGN and includes its current performance at the time of publication. The content primarily serves as a notificatio", "url": "https://ng.investing.com/news/stock-market-news/form-4-inogen-inc-for-9-july-93CH-2593317", "source_name": "Investing.com Nigeria", "published_at": "2026-07-09T14:10:00", "published_display": "09 Jul 2026 14:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen (INGN) EVP, COO Andrew Reding files baseline Form 3 insider report", "summary": "Inogen Inc.'s EVP and COO, Andrew P. Reding, has filed an initial Form 3 with the SEC, establishing his status as an insider with the company. This filing is a baseline report of beneficial ownership and does not indicate any purchases, sales, or other transactions of company sha", "url": "https://www.stocktitan.net/sec-filings/INGN/form-3-inogen-inc-initial-statement-of-beneficial-ownership-8b078c8ffe9c.html", "source_name": "Stock Titan", "published_at": "2026-07-09T13:11:02", "published_display": "09 Jul 2026 13:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen (INGN) EVP, COO awarded 130,000 restricted stock units vesting from 2026", "summary": "Inogen Inc.'s EVP and COO, Andrew P. Reding, has been granted 130,000 restricted stock units (RSUs). These RSUs will begin vesting on September 1, 2026, with one-third vesting after one year and the remaining units vesting in equal annual installments, contingent on his continued", "url": "https://www.stocktitan.net/sec-filings/INGN/form-4-inogen-inc-insider-trading-activity-bc352f9307cd.html", "source_name": "Stock Titan", "published_at": "2026-07-09T13:11:02", "published_display": "09 Jul 2026 13:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc (INGN) executive sells 10,938 shares in planned trade", "summary": "Jennifer M. Yi Boyer, EVP Enterprise Enablement and Chief HR Officer at Inogen Inc (INGN), sold 10,938 shares of company common stock for $6.5959 per share on July 1, 2026. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on February 27, 2026. ", "url": "https://www.stocktitan.net/sec-filings/INGN/form-4-inogen-inc-insider-trading-activity-e7258f38e9d2.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:10:13", "published_display": "06 Jul 2026 20:10", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INGN - Inogen Inc Volatility & Greeks", "summary": "This article provides a detailed overview of Inogen Inc (INGN) financial data, including its stock performance, volatility metrics, and various financial ratios. It covers key figures such as market capitalization, sales, earnings per share, insider and institutional ownership, a", "url": "https://finviz.com/stock?t=INGN&ta=1&p=d&ty=ocv&b=2&r=m3&e=2026-02-20", "source_name": "Finviz", "published_at": "2026-07-03T17:09:19", "published_display": "03 Jul 2026 17:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc (INGN) Slips Slightly Amidst Range-Bound Trading - Price Surge Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQaGlRWElIc3pBUHhZM0VJZm9qd1NGbTZKUC1zLTRsV0dzUGVoX2RMTG5EVm1HbW9oX1N5UHJOcTVuSlRpSjdUMzl2VS1FNlNCT19VRWQ2QUxfM1lpMUNSVkozbFRBeTBMekgzdmk5dDlhd3ExWEtFWHloN2hQQk9nUWNQdl9INDRZNGxkOFVyOTZ6S0lhN0NwSHQ5Ti1Xb2s?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Appoints New Chief Operating Officer for Growth", "summary": "Inogen has appointed Andy Reding as its new Chief Operating Officer, a move aimed at strengthening its leadership and execution capabilities to support diversification, new product launches, and geographic expansion. Reding brings over 30 years of experience in medical technology", "url": "https://www.theglobeandmail.com/investing/markets/stocks/INGN-Q/pressreleases/3106716/inogen-appoints-new-chief-operating-officer-for-growth/", "source_name": "The Globe and Mail", "published_at": "2026-07-03T03:10:14", "published_display": "03 Jul 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Announces the Appointment of Andy Reding as Chief Operating Officer", "summary": "Inogen, Inc. (Nasdaq: INGN) has appointed Andy Reding as its new Chief Operating Officer, a newly created role aimed at strengthening leadership and driving commercial and operational execution. Reding brings over 30 years of medical technology and commercial operations experienc", "url": "https://www.biospace.com/press-releases/inogen-announces-the-appointment-of-andy-reding-as-chief-operating-officer", "source_name": "BioSpace", "published_at": "2026-07-02T04:10:13", "published_display": "02 Jul 2026 04:10", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Appoints Reding to New COO Role", "summary": "Inogen has appointed Jason Reding as its new Chief Operating Officer, a newly created role within the company. Reding brings extensive experience in general management, operations, and supply chain across various industries, including medical devices. This strategic hire is expec", "url": "https://www.moomoo.com/news/post/72351373/inogen-appoints-reding-to-new-coo-role?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-02T03:10:14", "published_display": "02 Jul 2026 03:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Names Chief Operating Officer", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/inogen-names-chief-operating-officer-203207435.html", "source_name": "MT Newswires", "published_at": "2026-07-01T20:32:07+00:00", "published_display": "01 Jul 2026 20:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen appoints Andy Reding as chief operating officer", "summary": "Inogen Inc. has appointed Andy Reding as its new Chief Operating Officer, a newly created position aimed at strengthening its leadership structure. Reding brings over 30 years of experience in medical technology and will be responsible for revenue and operational performance, ali", "url": "https://www.investing.com/news/company-news/inogen-appoints-andy-reding-as-chief-operating-officer-93CH-4771445", "source_name": "Investing.com", "published_at": "2026-07-01T21:09:47", "published_display": "01 Jul 2026 21:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc SEC Filing", "summary": "This SEC Form 144 filing indicates a proposed sale of 10,770 shares of Inogen Inc. (INGN) common stock by Jennifer Yi Boyer, dated May 29, 2026, under a 10b5-1 plan. The filing also notes 10,938 Restricted Stock Units acquired on March 1, 2025, with Morgan Stanley Smith Barney LL", "url": "https://www.stocktitan.net/sec-filings/INGN/144-inogen-inc-sec-filing-e85f308712cd.html", "source_name": "Stock Titan", "published_at": "2026-07-01T21:09:47", "published_display": "01 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen (Nasdaq: INGN) adds COO Andy Reding with equity package", "summary": "Inogen (Nasdaq: INGN) has appointed Andy Reding as its new Chief Operating Officer, effective July 6, 2026, a newly created role to drive revenue, operations, and cross-functional execution for new products and geographic expansion. Reding's compensation package includes a $500,0", "url": "https://www.stocktitan.net/sec-filings/INGN/8-k-inogen-inc-reports-material-event-0b294382a61d.html", "source_name": "Stock Titan", "published_at": "2026-07-01T20:09:47", "published_display": "01 Jul 2026 20:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen adds a COO as it pushes new products and global expansion", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNd0V2UEVlSVlBT3dyNFR2aUR5aFZqNHBmWlByQzJCaTQxTURtVlF5Z0hNcnhjZlZNaEctTGRtMy1nVEVQa3pza3IyNXEyVTZraXY5NHZocVYtRjA1cVFhY2JnTHc5SkF5TXVhZEUtV0tueDNxZ1lGenI3RVFpS216QXVXbHVYOGo1R0J6ZFZCeHJrTjROeFhXOVE5RmxGeWx3bGhaMHFlQXBGdUNjRnhCX2ZSTEZtWFB4SkJRMDNB?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] Inogen Inc SEC Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPWVBHQUhQYU9FYlYtOUcxVXhEOTRHWW5zYktKZkNSOGlIY0tmam5HZGVCVUtmVlc3SGlDbXpDNnlfRXlCelhyWEdKY25TdHh5aVZKUHhHWkd2VDFZM2dEdWhZWWxCVkdEdVJYRUZRTF9KM0NLZThQWkVyd2h3NnBFWXAyNTM1N3V6WmVVYmh3bWk?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen, Inc. Financial Disclosures & Filings", "summary": "This page provides a comprehensive list of Inogen, Inc.'s financial disclosures and filings, including earnings reports, annual general meetings, corporate presentations, and investor conference transcripts from 2022 to 2026. These documents offer insights into the company's fina", "url": "https://www.tradingview.com/symbols/LSX-A1XB32/documents/", "source_name": "TradingView", "published_at": "2026-07-01T03:40:59", "published_display": "01 Jul 2026 03:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen, Inc. Actuals & Estimates (NASDAQ:INGN)", "summary": "This article provides an overview of Inogen, Inc.'s (NASDAQ: INGN) financial actuals and estimates, including its current stock price, historical performance, analyst forecasts, and upcoming earnings report. It highlights the company's financial data, such as market capitalizatio", "url": "https://www.tradingview.com/symbols/NASDAQ-INGN/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T05:40:29", "published_display": "27 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen, Inc. Actuals & Estimates (SWB:6IO)", "summary": "This article provides financial actuals and estimates for Inogen, Inc. (SWB:6IO), including income statement, balance sheet, and cash flow data, alongside analyst price targets. It details the company's past earnings and revenue, future earnings report dates, and key financial me", "url": "https://www.tradingview.com/symbols/SWB-6IO/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T01:40:29", "published_display": "27 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Inogen, Inc \u2013 NASDAQ:INGN", "summary": "This article displays the \"Price to sales forward\" metric for Inogen, Inc (NASDAQ: INGN) on the TradingView platform. The content is primarily a representation of financial data for the company, showing a period, value, change, and percentage change without specific figures in th", "url": "https://www.tradingview.com/symbols/NASDAQ-INGN/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T18:40:29", "published_display": "26 Jun 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Inogen, Inc \u2013 NASDAQ:INGN", "summary": "This article provides financial information for Inogen, Inc (NASDAQ: INGN), specifically its enterprise value to revenue forward. It appears to be a stub or an incomplete data entry from a financial platform like TradingView, as it lacks detailed analytical content beyond the sta", "url": "https://www.tradingview.com/symbols/NASDAQ-INGN/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T18:39:30", "published_display": "26 Jun 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision Trading with Inogen Inc (INGN) Risk Zones", "summary": "This article provides a precision trading analysis for Inogen Inc (INGN), detailing neutral readings in shorter horizons and suggesting an easing of a long-term weak bias. It highlights an exceptional 49.5:1 risk-reward setup targeting a 15.8% gain versus 0.3% risk, and outlines ", "url": "https://news.stocktradersdaily.com/news_release/22/Precision_Trading_with_Inogen_Inc_INGN_Risk_Zones_061926123202_1781886722.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-19T12:32:01", "published_display": "19 Jun 2026 12:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc (INGN) Institutional Confidence", "summary": "The article analyzes Inogen Inc's (INGN) institutional confidence score, which is currently 7.00, placing it 79th in its industry. Institutional shareholding rose by 4.39% quarter-over-quarter to 75.89%, with Steven Cohen being the largest shareholder despite a slight decrease in", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ingn/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T08:14:46", "published_display": "18 Jun 2026 08:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc (INGN) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Inogen Inc (INGN), outlining its major shareholders and institutional holdings. It provides a breakdown of shareholder types, including investment advisors, hedge funds, and corporations, and tracks changes in institutional shareh", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ingn/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T09:41:18", "published_display": "17 Jun 2026 09:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc (INGN) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE5xWmlNOE8zUU9BcDFXUlJxNWJQYTFYVGJwS0FrZ0tqQUVldklFLTFQZUtGbWgxY1J2WDhiaWlsT2toRE84VlBTeDBIaUs5X21Zbm1RUU05QzZLVWhOMDFla3dfNmFGMFI5VEJuWUFTTGpKWHA3Z1FHMQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-16T22:51:25+00:00", "published_display": "16 Jun 2026 22:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc (INGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a brief overview of Inogen Inc's (INGN) revenue breakdown by region, indicating that 60.18% of its revenue comes from the U.S. and 39.82% from non-U.S. sources. It also lists various financial reporting periods (FY2025-FY2020) but states that relevant data f", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ingn/revenue", "source_name": "TradingKey", "published_at": "2026-06-16T22:39:52", "published_display": "16 Jun 2026 22:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc (INGN) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of Inogen Inc (INGN), highlighting its current market data and valuation score. The company's valuation score is 8.86, placing it 63rd in the Healthcare Equipment & Supplies industry. Key financial ratios like P/E, P/B, P/S, and P/CF are", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ingn/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-16T20:10:03", "published_display": "16 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc (INGN) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for Inogen Inc (INGN), highlighting its current earnings forecast score, average price target, and analyst ratings. Based on three analysts, the stock has an average target price of $13.00, with a \"Buy\" recommendation. The article also i", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ingn/earnings", "source_name": "TradingKey", "published_at": "2026-06-16T19:41:18", "published_display": "16 Jun 2026 19:41", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Inc Stock (US45780L1044): Valuation metrics under the microscope", "summary": "This article examines the valuation metrics of Inogen Inc (INGN), a medical technology company specializing in portable oxygen concentrators. Due to recent operating losses, traditional price-earnings ratios are not relevant; instead, investors focus on price-to-sales and enterpr", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/inogen-inc-stock-us45780l1044-valuation-metrics-under-the-microscope/69547852", "source_name": "AD HOC NEWS", "published_at": "2026-06-15T21:09:50", "published_display": "15 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INGN SEC Filings - Inogen Inc 10-K, 10-Q, 8-K Forms", "summary": "This page on StockTitan provides a comprehensive resource for Inogen Inc. (INGN) SEC filings, including 10-K annual reports, 10-Q quarterly reports, and 8-K material event disclosures. It details Inogen's business in respiratory medical technology and lists recent filings with AI", "url": "https://www.stocktitan.net/sec-filings/INGN/page-5.html", "source_name": "Stock Titan", "published_at": "2026-06-12T18:40:41", "published_display": "12 Jun 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen (INGN) director awarded 28,081 RSUs, boosting share holdings", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOVGVUU0lZdUZLNVk5RWR2NklRakFHUlUwaUpvS0NPbWRib09SUzFvdkU5X0RGQ3ZRZFdzMUEteXNseDdKcUJhRm5uRVBPMS12MFNXS3Y0XzNaME1NRlZIRTNGZ1ZZS21WU1RkNmE1NzRXRVA2T3B0ZFZpUFhvdDE4WWdEaTVvaTE3dDFORlpxUC1BbGprU1NNaFA5TmRaX3Q0UVhlSjd6QQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why You Should Retain Inogen Stock in Your Portfolio for Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQaGV1SXNpOVN2R19UNm5PVkpFVlVyaklQYThQd1dVWFdfYllPWkltdnh6Q1padkZ2S3VSeWlaMTEzeTdUNWM4bHdpRTU2cnYyQ2o3UXBpRFdlaXBHR1RsQ3NIMEtGTGQ3ZjJ2c3dyQ0l0bTE0dU9ycEIxTnJVVVpZMWg2UEx5b1dBd3NaeG5ibFZwOURWcFR1NDMxYnEyVkU?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Inogen (INGN) Story Is Shifting With New Targets And Execution Questions", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOZUIwNkhCNk9RZXczTmhfbjdiNkNUb2Z5LTZjMnFrbWhaV09BU1B5VTV1Z1VrNUJXamNtd2hnWDJiRTc4S0tzUHVTUzQtNEZiZmt2U1NKdUYtU2NZZVJGdnF5ME9xLWNORGpOLTBteE5raGJWTC0tb0FpRXpFaXl1OEttSS1jSG9qV2JHdDUwaWtoNW5kdV9qZXRKb0dVU2dN?oc=5", "source_name": "Market source", "published_at": "2026-05-10T07:00:00+00:00", "published_display": "10 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen (INGN) Reports Strong Q1 Revenue Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNRUxaUjhwbzhOUnNlUDVDTm5GQTdfUHQ0NFl1SUhoQkpELXZtdmp1Q2lyTHhDVUZwS2J0bTlVbUMxek1seVU1TVRpSXBZOUpycms2d2g5eDVlc0hFejFsZTJWbUQxMEpsMWZlUFZoLTlHNEZ6YkhDNGxVVk1IYmx5UG83YS1GTVd2STN3and1TlBvZVdwUW9vUHlEYw?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNTEpTSHZKNE93eE5YNDJDcVJEYXd6M3lLODlPRFpudEhfbG1KMWpLMDRKUDFpdTFVa0QtdzZpekNOdW9fdVRDYnFNMDluQ1FnRXUtOGhhMURadFBHMmJaaHJIWkJ4SEtQdEgwX2pUektqbnNsMGM3UUZQZXdlYTNBdTRodmlKdlhjNDBhVjYxQmlDbWhvblNvdFRpUmI?oc=5", "source_name": "Market source", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/f03564eb-3491-37ce-a5a4-07799bf50b8a/inogen-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-08T04:06:43+00:00", "published_display": "08 May 2026 04:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen (INGN) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/ab29362c-427b-38f6-8db8-d8a6f09fd441/inogen-%28ingn%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-08T00:08:25+00:00", "published_display": "08 May 2026 00:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen (INGN) Reports Q1 Loss, Beats Revenue Estimates", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/inogen-ingn-reports-q1-loss-230522436.html", "source_name": "Zacks", "published_at": "2026-05-07T23:05:22+00:00", "published_display": "07 May 2026 23:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We're Not Very Worried About Inogen's (NASDAQ:INGN) Cash Burn Rate", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPcVN3N012OUhRQUZXTTFIVkI0b1ozUVAzWDNiaG9UZzJQeDdZMm5taEtXV21vZy1SV1JuejJJUFpJcExpZjlBTVluM1pOVmtXbmRnWTFyUmJmWkZSNGVBWWttdzhfMEZqbFRJTnVtUER4WE5kWW9QMlNrdFFFZ2RYQXVYRnRSNmM2Y01ocW5keEFSRHVWR2s1TUNB?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen (INGN) Surges 6.9%: Is This an Indication of Further Gains?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPS0dFNWVfdzhWejY0Vm9lTU9jM2Y5eUJWTDZ2YTlQaGlIMmVqeHk5YVE1MU5zWVE0WUJiOVdRb3REbkVBUnYxMERuOWNOcEFmbXRFM1I5eWlVLVg4Q3phaGJpVFQ1UzcxWmNrVDlwdFdlM1diV3hzaE5MeVdhaUdVZklVamphVDFwaE1LRTV3YnU?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen (NASDAQ:INGN shareholders incur further losses as stock declines 11% this week, taking five-year losses to 86%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why You Should Add Inogen Stock to Your Portfolio Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPX0wzOXJSYzZ1MDhYS2E1UEdvMmlTZ3dENzNJU0V6SlQ2NnlSeC1xQUoyQnoxQzNBSXQ1ZEFrSGJpNHZMSjVHc1ZtUmpwWHZoalhQelQ0Y0pwcnViZC05aUNEUXlla0JmdmxseFJLLVZGc0tfSWd0WE1PZDcyOFpvVUhSOTROZHVKbGkyNlYtSUhFcUQyTmlzbTR6QWhNUmRsaW9WQ2xXSW9EQlRKX3cyaVZhanJRWVk?oc=5", "source_name": "TradingView", "published_at": "2025-07-16T07:00:00+00:00", "published_display": "16 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inogen launches Voxi 5 stationary oxygen concentrator for long-term care patients", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPZWxsUm9IbUxZRVdMQXk4Qm5HUkZoU2JkTXdwRlBDNDVxR1I5Tk5FTV82b21NbWlrSUZENzZadWNJWjQxeVRvVFhjZ0M2UWFBQkRReGN0eVNGUzk3Rmp3VlNRc0NWSW9HaFNYTF9aM2dmaVpfcDQ5X2FyOVpzSEJOM2Z6eXJLa01wUWUwZGQxRXB4MFJTSzY4NThxZGFrTEptcXhSZG9zT20yUlQ5WUJsZ0xrTW11Tl85Tnc0?oc=5", "source_name": "Medical Economics", "published_at": "2025-06-23T07:00:00+00:00", "published_display": "23 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Yuwell to invest $27m in Inogen to boost oxygen potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPeVpmSjNzdllBSkNoMzhUSm95Vl9sY25rSUZqYkVONEJwMG9qWWFodHBER1E2VFlBaTZuWlFaUFhrV0J4YnVteWo2dDZVQm8ycnU0VHNuZFM1UXM1WF94cEstQVlWZEdNRWxKQTVOdFdnaE1fd0oyV0Z5Rno5UDVMNGlvX1ZzVTMwQ2w5Yk9qcWxtRkZ6LV8wX3hPcTFHU3Iwd2Z6ZWU3cw?oc=5", "source_name": "gasworld", "published_at": "2025-01-28T08:00:00+00:00", "published_display": "28 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 93, "total_relevant": 61, "sentiment_summary": {"positive": 11, "negative": 2, "neutral": 48, "score": 53, "total": 61, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 77, "events": [{"event": "general", "label": "Market update", "weight": 15.95, "count": 29}, {"event": "earnings", "label": "Earnings", "weight": 14.79, "count": 29}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 11, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 6.54, "latest_week": "2026-07-10", "one_week_move": -0.9, "four_week_move": 2.2, "twelve_week_move": -4.1, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.179424, "market_dynamics_buy_signal": false, "relative_strength": -19.158371, "fair_value_gap": -13.3, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.8163, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.9% over one week, +2.2% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 51, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 14}, {"label": "Stock Titan", "count": 10}, {"label": "TradingView", "count": 6}, {"label": "TradingKey", "count": 6}, {"label": "Moomoo", "count": 2}, {"label": "StockStory", "count": 2}, {"label": "Bitget", "count": 1}, {"label": "scanx.trade", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 50}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 29}, {"label": "Market update", "count": 29}, {"label": "Macro sensitivity", "count": 1}, {"label": "Balance sheet", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "50", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-0.9% over one week, +2.2% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Inogen to report Q2 2026 results after market close, host conference call"}], "updated_at": "2026-07-17T08:59:03.128152+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}